Suchergebnisse - "Hsieh, Yao-Yu"

PubPharm (48)

1

Unveiling IL6R and MYC as Targeting Biomarkers in Imatinib-Resistant Chronic Myeloid Leukemia through Advanced Non-Invasive Apoptosis Detection Sensor Version 2 Detection

enthalten in: Cells | 2024

von Lee, C. | Hsu, K. | Hsieh, Y. | +4

2

Ten-year epidemiology and risk factors of cytomegalovirus infection in hematopoietic stem cell transplantation patients in Taiwan

enthalten in: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 2024

von Huang, Y. | Hsiao, F. | Guan, S. | +20

3

Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer : A Randomized Clinical Trial

enthalten in: JAMA oncology | 2024

von Chen, T. | Dai, M. | Tseng, L. | +17

4

Repositioning VU-0365114 as a novel microtubule-destabilizing agent for treating cancer and overcoming drug resistance

enthalten in: Molecular oncology | 2024

von Hsieh, Y. | Du, J. | Yang, P.

5

Repositioning VU‐0365114 as a novel microtubule‐destabilizing agent for treating cancer and overcoming drug resistance

enthalten in: Molecular Oncology | 2024

von Hsieh, Y. | Du, J. | Yang, P.

6

LAMC2 is a potential prognostic biomarker for cholangiocarcinoma

enthalten in: Oncology letters | 2023

von Ong, K. | Hsieh, Y. | Lai, H. | +11

7

Cartilage oligomeric matrix protein overexpression is an independent poor prognostic indicator in patients with intrahepatic cholangiocarcinoma

enthalten in: Scientific reports | 2023

von Ong, K. | Hsieh, Y. | Lai, H. | +12

8

Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma : A Potential Theranostic Biomarker

enthalten in: Diagnostics (Basel, Switzerland) | 2023

von Ong, K. | Hsieh, Y. | Sun, D. | +6

9

Efficacy and Safety of a Parenteral Nutrition Program for Patients with RAS Wild-Type Metastatic Colorectal Cancer Administered First-Line Cetuximab Plus Chemotherapy : A Propensity Score Matching Study

enthalten in: Nutrients | 2023

von Chang, Y. | Chen, C. | Chang, S. | +15

10

Survival benefit of metastasectomy in first-line cetuximab therapy in patients with RAS wild-type metastatic colorectal cancer : a nationwide registry

enthalten in: American journal of cancer research | 2023

von Chen, C. | Chang, S. | Chang, Y. | +15

1
2
3
4
5
Nächster »
[5]